137 related articles for article (PubMed ID: 32777077)
1. Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells.
Wijaya RS; Read SA; Selvamani SP; Schibeci S; Azardaryany MK; Ong A; van der Poorten D; Lin R; Douglas MW; George J; Ahlenstiel G
J Infect Dis; 2021 Apr; 223(7):1183-1195. PubMed ID: 32777077
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
3. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.
Serti E; Chepa-Lotrea X; Kim YJ; Keane M; Fryzek N; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2015 Jul; 149(1):190-200.e2. PubMed ID: 25754160
[TBL] [Abstract][Full Text] [Related]
4. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells in hepatitis C: Current progress.
Yoon JC; Yang CM; Song Y; Lee JM
World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
[TBL] [Abstract][Full Text] [Related]
6. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.
Wang JM; Cheng YQ; Shi L; Ying RS; Wu XY; Li GY; Moorman JP; Yao ZQ
J Virol; 2013 Nov; 87(21):11626-36. PubMed ID: 23966413
[TBL] [Abstract][Full Text] [Related]
7. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Bartres C; González P; García-López M; Pose E; Lens S; Maini MK; Forns X; Koutsoudakis G
Front Immunol; 2020; 11():129. PubMed ID: 32161581
[No Abstract] [Full Text] [Related]
8. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
9. Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.
Serti E; Park H; Keane M; O'Keefe AC; Rivera E; Liang TJ; Ghany M; Rehermann B
Gut; 2017 Apr; 66(4):724-735. PubMed ID: 26733671
[TBL] [Abstract][Full Text] [Related]
10. Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
Spaan M; van Oord G; Kreefft K; Hou J; Hansen BE; Janssen HL; de Knegt RJ; Boonstra A
J Infect Dis; 2016 Jan; 213(2):216-23. PubMed ID: 26223768
[TBL] [Abstract][Full Text] [Related]
11. Effect of Combined HCV Therapy on Natural Killer Cell Activity.
Abd-Elsamie E; Kamal-ElDin TM; Hassaballa AE; A M; Badawy ER; ElMelegy TT; Zahran AM; Mekky MA
Egypt J Immunol; 2019 Jan; 26(1):151-161. PubMed ID: 31333005
[TBL] [Abstract][Full Text] [Related]
12. Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.
Mele D; Oliviero B; Mantovani S; Ludovisi S; Lombardi A; Genco F; Gulminetti R; Novati S; Mondelli MU; Varchetta S
Hepatology; 2021 Jan; 73(1):79-90. PubMed ID: 32281670
[TBL] [Abstract][Full Text] [Related]
13. [Alteration of CD100 expression on natural killer cells in chronic patients with hepatitis C virus before and after initiation of antiviral treatment].
He Y; Li B; Zhou Y; Zhang Y; Guo Y; Ji G; Fan C; Jia Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):856-60. PubMed ID: 25108441
[TBL] [Abstract][Full Text] [Related]
14. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients.
Adenugba A; Hornung M; Weigand K; Peschel G; Junger H; Kupke P; Lang H; Marquardt JU; Zimmermann T; Geissler EK; Schlitt HJ; Werner JM
Transplantation; 2021 Oct; 105(10):2226-2238. PubMed ID: 33587435
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
[TBL] [Abstract][Full Text] [Related]
17. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H
J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290
[TBL] [Abstract][Full Text] [Related]
18. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
19. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
[TBL] [Abstract][Full Text] [Related]
20. Control of HCV Infection by Natural Killer Cells and Macrophages.
Rosen HR; Golden-Mason L
Cold Spring Harb Perspect Med; 2020 Sep; 10(9):. PubMed ID: 31871225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]